NCT07159607View on ClinicalTrials.gov

Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 17, 2025

Primary Completion Date

July 16, 2030

Study Completion Date

July 16, 2030

Conditions
IDH-mutant Glioma (Oligodendroglioma, Astrocytoma)
Trial Locations (2)

1090

RECRUITING

Medical University of Vienna, Vienna

81377

RECRUITING

LMU Hospital, Munich

All Listed Sponsors
collaborator

Servier Affaires Médicales

INDUSTRY

collaborator

Servier Deutschland GmbH

INDUSTRY

lead

LMU Klinikum

OTHER

NCT07159607 - Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR) | Biotech Hunter | Biotech Hunter